Last reviewed · How we verify
NCT05339828
Unroofing Curettage for Pilonidal Disease
trial testing unroofing curettage in Pilonidal Disease in 203 participants. Completed in 5 May 2022.
2 May 2022
Quick facts
| Lead sponsor | Ankara Diskapi Training and Research Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 203 |
| Start date | 27 April 2022 |
| Primary completion | 2 May 2022 |
| Estimated completion | 5 May 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- unroofing curettage
Conditions studied
- Pilonidal Disease — all drugs for Pilonidal Disease →
- Recurrence — all drugs for Recurrence →
- Healing Wound — all drugs for Healing Wound →
Sponsor
Ankara Diskapi Training and Research Hospital
Who can join
18 and older, any sex, with Pilonidal Disease or Recurrence. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aimed to investigate the outcomes of patients who underwent UC as the primary intervention for simple or complex SPD
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Unroofing curettage for treatment of simple and complex sacrococcygeal pilonidal disease.
Olcucuoglu E, Şahin A. · · 2022 · cited 3× · PMID 36304191 · DOI 10.4174/astr.2022.103.4.244
Verify or expand the search:
- PubMed search for NCT05339828
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pilonidal Disease
Currently open trials in the same condition.
- NCT07321704 — Effect of Antiseptic Irrigations With 0.05% Chlorhexidine Gluconate (Irrisept) Versus Normal Saline on Fasciocutaneous F · NA · recruiting
- NCT06406621 — Pilot Trial Assessing the Effectiveness of Laser Hair Depilation on Pilonidal Disease Recurrence in Patients With Darker · NA · recruiting
- NCT06286397 — Topical Anti-Androgens in Pilonidal Sinus Disease · Phase 2 · recruiting
- NCT06391307 — The Role of Mesenchymal Stem Cell and Exosome in Treating Pilonidal Sinus Disease in Children · NA · recruiting
- NCT03772873 — MIPE for Pilonidal Disease · active not recruiting
Other Ankara Diskapi Training and Research Hospital trials
Trials by the same sponsor.
- NCT07114965 — Effects Of Quadratus Lumborum Type 1 Block And Transversalis Facial Plane Block On Acute Pain In Gynecological Surgery · active not recruiting
- NCT05945706 — Evaluation of Renal Resistive Index in Patients with Controlled Hypotension · completed
- NCT05813977 — Amount of Droplet Formed During Percutaneous Dilatational Tracheostomy · NA · completed
- NCT05409690 — Renal Arterial Resistive Index for Differential Diagnosis of Acute Kidney Injury · unknown
- NCT05303441 — The Predictive and Diagnostic Value of Cystatin C and High Sensitive Troponin · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05339828 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ankara Diskapi Training and Research Hospital
- Last refreshed: 27 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05339828.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing